Virax Biolabs

Based in Scotland, Virax Biolabs is an innovative biotech company focused on the detection of immune response outcomes for research and diagnostics.

We provide the research community with high-performance assays and reagents designed to facilitate the study of antigen specific immune responses including T cell activation, dysfunction, or exhaustion. Alongside our research tools, Virax Biolabs is actively developing ViraxImmune™, a pioneering diagnostic pipeline for post-acute infection syndromes (PAIS), such as Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-Treatment Lyme Disease Syndrome.

Our commitment to quality is backed by our ISO 9001 and ISO 13485 certifications, ensuring excellence in both general operations and medical device standards. Achieving these certifications demonstrates our dedication to ensuring consistency, compliance, and confidence in everything we deliver.

ImmuneSelect and Research Solutions

Our growing portfolio of ImmuneSelect immune profiling tools and T cell assays are designed to meet the practical needs of immunology labs. We focus on providing affordable, easy-to-use solutions for researchers monitoring immune responses.

Alongside our product range, we provide a variety of immunology lab services. Our team has experience in a range of advanced analytical techniques, such as ELISA, ELISpot, FluoroSpot, and flow cytometry assays. These services are intended to provide reliable data to support your existing projects and workflows.

We also offer a range of tailored services to meet individual research requirements, with expertise in recombinant antibody and protein/peptide production, as well as protein sequencing and antibody engineering. Whether you require specific protein/peptide synthesis or technical assistance with an assay, we can work with you to find a solution that fits your requirements.